• 1
    Cabot AT. The question of castration for enlarged prostate. Am Surg 1896; 24: 265
  • 2
    Huggins C, Hodges GV. Studies on prostate cancer. I. The effect of castration, estrogen and androgen injections on serum phosphatases in Metastatic carcinoma of the prostate. Cancer Res 1941; 1: 2935
  • 3
    Chakrarart S, Collins WP, Newton JR, Oram DH, Judd JWW. Hormone profiles after the menopause. Br Med J 1976; 2: 784
  • 4
    Beland G, Elhilal M, Fradet Y et al. Total androgen blockade vs castration in metastatic cancer of the prostate. In MoltaL, SerioM, eds, Hormonal Therapy of Prostatic Disease: Basic and Clinical Aspects. Proceeding of an International Symposium, Milan, Italy April 6–8. Medicom, 1987: 302
  • 5
    Charig CR, Rundle JS. Flushing. Long-term side effects of orchidectomy in treatment of prostatic cancer. Urology 1989; 33: 175
  • 6
    Frodin T, Alund G, Varenhorst E. Measurement of skin blood flow and water evaporation as a means of objectively assessing hot flushes after orchidectomy in patient with prostatic cancer. Prostate 1985; 7: 203
  • 7
    Leuprolide Study Group. Leuprolide vs. diethylstilbestrol for metastatic prostate cancer. N Engl J Med 1984; 311: 12816
  • 8
    Presant CA, Soloway MS, Klioze SS et al. Buserelin treatment of advanced prostatic cancer. Cancer 1987; 59: 17136
  • 9
    Holdaway IM, Ibherston HK, Croxson MS, Harvey V, Boulton J. Treatment of metastatic prostate cancer with depot LH-RH analogue Zoladex. Prostate 1988; 12: 11927
  • 10
    Campbell S, Whitehead MI. Estrogen therapy and the postmenopausal syndrome. Clin Obstet Gynecol 1977; 4: 31
  • 11
    Coope J, Thompson JM, Foller L. Effects of ‘natural estrogen’ replacement therapy on menopausal symptoms and blood clotting. Br Med J 1975; 4: 139
  • 12
    Hammond CB, Maxson WS. Estrogen replacement therapy. Clin Obstet Gynecol 1986; 29: 407
  • 13
    Albright F. Studies on ovarian dysfunction III. The menopause. Am J Obstet Gynecol 1976; 126: 165
  • 14
    Studd J, Chakrararti S, Oram D. The climacteric. Clin Obstet Gynaecol 1977; 4: 3
  • 15
    Casper RF, Yen SSC, Wilker MM. Menopausal flushes: a neuroendocrine link with pulsatile luteinizing hormone secretion. Science 1979; 205: 823
  • 16
    Tatayn IV, Meldrum DR, Lu KH et al. LH, FSH and skin temperature during the menopausal hot flush. J Endocrinol Metab 1979; 59: 152
  • 17
    Daw E. Luteinizing hormone (LH) changes in female undergoing artificial menopause. Curr Med Res Opin 1974; 2: 256
  • 18
    Askel S, Schomberg D, Tyey L et al. Vasomotor symptoms, serum estrogen and gonadotrophin levels in surgical menopause. Am J Obstet Gynecol 1976; 126: 165
  • 19
    Beckman AL. Effect of intrahypothalamic norepinephrine on thermoregulatory responses in the rat. Am J Physiol 1970; 218: 1596604
  • 20
    Ball P, Knuppen R, Haupt O et al. The excretion of 2-hydroxyestrone during the menstrual cycle. J Clin Endocrinol Metab 1975; 40: 406
  • 21
    Paul SM, Axelrod J. Catechol estrogen – presence in brain and endocrine tissues. Science 1977; 197: 657
  • 22
    Stubbs WA, Jones A, Edwards CRW et al. Hormonal and metabolic responses to an enkephalin analogue in normal man. Lancet 1978; 2: 1225
  • 23
    Lightman SI, Jacobs HS, Maguire AK et al. Climacteric flushing. Clinical and endocrine response to infusion of naloxone. Br J Obstet Gynaecol 1981; 88: 919
  • 24
    De Fazio J, Verhengen C, Chetkewski R et al. The effects of naloxone on hot flushes and gonadotrophin secretion in post-menopausal women. J Clin Endocrinol Metab 1984; 58: 578
  • 25
    Dyer RG, Grossman R. Opioid modulation of the response of preoptic neurones to stimulation of the ventral noradrenergic tract in female rats. J Physiol 1988; 400: 63144
  • 26
    Fishman J, Norton BJ, Hann EF. Opiate regulation of estradiol-2-hydroxylase in the brain of female rats: Mechanism for control of pituitary hormone secretion. Proc Natl Acad Sci USA 1980; 77: 2574
  • 27
    Maatman TJ, Gupta MK, Monte JE. Effectiveness of castration versus intravenous estrogen in producing rapid endocrine control of metastatic cancer of prostate. J Urol 1985; 133: 6201
  • 28
    Smith JA. Management of hot flushes due to endocrine therapy for prostate cancer. Oncology 1996; 10: 131922
  • 29
    Buchholz NP, Mattarelli G. Hot flushes after orchidectomy in treatment of prostate cancer – a serious side effect. Zeitschrift fur Gerontologie 1994; 27: 3346
  • 30
    Sarosoly MF, Schellhamner PF, Soloway MS et al. Endocrine effects, efficacy and tolerability of a 10.8 mg depot formulation of goserelin acetate administered every 13 weeks to patients with advanced prostate cancer. BJU Int 1999; 83: 8016
  • 31
    Parmar H, Edwards L, Phillips RH, Allen L, Lightman SC. Orchidectomy versus long acting D-Trip-6-LHRH in advanced prostate cancer. Br J Urol 1987; 59: 248
  • 32
    Smith JA. A prospective comparison of treatments for symptomatic hot flushes following endocrine therapy for cancer of the prostate. J Urol 1994; 152: 1324
  • 33
    Miller JI, Ahmann FR. Treatment of castration-induced menopausal symptoms with low dose diethylstilbestrol in men with advanced prostate cancer. Urology 1992; 40: 499502
  • 34
    Townsend PT, Dyer GI, Young O et al. The absorption and metabolism of oral estradiol, estrone and estriol. Br J Obstet Gynecol 1981; 88: 84652
  • 35
    Gerber GS, Zayaja CP, Ray PS, Rukstalis DB. Transdermal estrogen in the treatment of hot flushes in men with prostate cancer. Urology 2000; 55: 97101DOI: 10.1016/s0090-4295(99)00370-2
  • 36
    Loprinzi CL, Michalak JC, Quella SK et al. Megestrol acetate for the prevention of hot flushes. N Engl J Med 1994; 331: 34752
  • 37
    Ronzoni G, Giovanni L, Menchinelli P, Meneschincheri M. Therapy of vasomotor syndrome in the treatment of advanced prostatic cancer: apropos of 37 cases. Arch Ital Urol Androl 1998; 70: 3740
  • 38
    Eaton AC, McGuire N. Cyproterone acetate in the treatment of post-orchidectomy hot flushes. Double-blind cross-over trial. Lancet 1983; 2: 1336
  • 39
    Moon TD. Cyproterone acetate for treatment of hot flushes after orchidectomy. Letter. J Urol 1985; 134: 155
  • 40
    Clayden JR, Bell JW, Bollard P. Menopausal flushing. double blind trial of a non-hormonal medication. Br Med J 1974; 1: 40912
  • 41
    Bolli P, Simpson FO. Clonidine in menopausal flushing: a double-blind trial. NZ Med J 1975; 82: 1967
  • 42
    Freedman RR, Woodward S, Sabharwal SC. α2-adrenergic mechanism in menopausal hot flushes. Obstet Gynecol 1990; 76: 5737
  • 43
    Ranvikar V. Physiology and treatment of hot flushes. Obstet Gynecol 1990; 75: 3S7S
  • 44
    Jones KP, Ranvikar V, Schiff I. A preliminary evaluation of the effect of lofexidine on vasomotor flushes in post-menopausal women. Maturitas 1985; 7: 1359
  • 45
    Laufer LR, Erlik Y, Meldrum DP, Judd HL. Effect of clonidine on hot flushes in post-menopausal women. Obstet Gynecol 1982; 60: 5836
  • 46
    Parra RO, Gregory JG. Treatment of post-orchidectomy hot flushes with transdermal administration of clonidine. J Urol 1990; 143: 753
  • 47
    Hammar M, Frisk J, Grimas O, Hook M, Spetz AC, Wyon Y. Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: a pilot study. J Urol 1999; 161: 8536
  • 48
    Towlerton G, Filshie J, O'Brien M, Duncan A. Acupuncture in the control of vasomotor symptoms caused by tamoxifen. Palliat Med 1999; 13: 445


  1. Authors

C. Kouriefs, MB, ChB, MRCS(Eng), Research Registrar in Urology.

M. Georgiou, MB, ChB, Specialist Registrar in Obstetrics and Gynaecology.

R. Ravi, MS, MCh, FRCS(Glas), FRCSEd(Gyn), FRCS(Urol), FEBU, Consultant Urologist.


cyproterone acetate